Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

HIV AND HEPATITIS POLICY INSTITUTE

Filed by KAMRAN DARAVI CONSULTING LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
Registration
Posted
Oct 28, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
7390e3d5-56c5-4aa1-9e91-4b40fc92d1b4
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Lobbying for domestic HIV prevention and treatment, viral hepatitis and patient access and affordability of prescription drugs.

HCR · Health Issues

Lobbying for domestic HIV prevention and treatment, viral hepatitis and patient access and affordability of prescription drugs.

INS · Insurance

Lobbying for domestic HIV prevention and treatment, viral hepatitis and patient access and affordability of prescription drugs.

MMM · Medicare/Medicaid

Lobbying for domestic HIV prevention and treatment, viral hepatitis and patient access and affordability of prescription drugs.

PHA · Pharmacy

Lobbying for domestic HIV prevention and treatment, viral hepatitis and patient access and affordability of prescription drugs.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.